Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Sep 6:2:46.
doi: 10.1186/1477-7525-2-46.

Impairments, activity limitations and participation restrictions: prevalence and associations among persons living with HIV/AIDS in British Columbia

Affiliations

Impairments, activity limitations and participation restrictions: prevalence and associations among persons living with HIV/AIDS in British Columbia

Melanie Rusch et al. Health Qual Life Outcomes. .

Abstract

Background: To measure the prevalence of and associations among impairments, activity limitations and participation restrictions in persons living with HIV in British Columbia to inform support and care programs, policy and research.

Methods: A cross-sectional population-based sample of persons living with HIV in British Columbia was obtained through an anonymous survey sent to members of the British Columbia Persons With AIDS Society. The survey addressed the experience of physical and mental impairments, and the experience and level of activity limitations and participation restrictions. Associations were measured in three ways: 1) impact of types of impairment on social restriction; 2) impact of specific limitations on social restriction; and 3) independent association of overall impairments and limitations on restriction levels. Logistic regression was used to measure associations with social restriction, while ordinal logistic regression was used to measure associations with a three-category measure of restriction level.

Results: The survey was returned by 762 (50.5%) of the BCPWA participants. Over ninety percent of the population experienced one or more impairments, with one-third reporting over ten. Prevalence of activity limitations and participation restrictions was 80.4% and 93.2%, respectively. The presence of social restrictions was most closely associated with mental function impairments (OR: 7.0 for impairment vs. no impairment; 95% CI: 4.7 - 10.4). All limitations were associated with social restriction. Among those with <or= 200 CD4 cells/mm3, odds of being at a higher restriction level were lower among those on antiretrovirals (OR: 0.3 for antiretrovirals vs. no antiretrovirals; 95% CI: 0.1-0.9), while odds of higher restriction were increased with higher limitation (OR: 3.6 for limitation score of 1-5 vs. no limitation, 95%CI: 0.9-14.2; OR: 24.7 for limitation score > 5 vs. no limitation, 95%CI: 4.9-125.0). Among those with > 200 CD4 cells/mm3, the odds of higher restriction were increased with higher limitation (OR: 2.7 for limitation score of 1-5 vs. no limitation, 95%CI: 1.4-5.1; OR: 8.6 for limitation score > 5 vs. no limitation, 95%CI: 3.9-18.8), as well as by additional number of impairments (OR:1.2 for every additional impairment; 95% CI:1.1-1.3).

Conclusions: This population-based sample of people living with HIV has been experiencing extremely high rates of impairments, activity limitations and participation restrictions. Furthermore, the complex inter-relationships identified amongst the levels reveal lessons for programming, policy and research in terms of the factors that contribute most to a higher quality of life.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prevalence of specific impairments for participants with CD4 counts ≤ 200 cells/mm3 (speckled bars), 201 to 500 cells/mm3 (downward diagonally-striped bars) and > 500 cells/mm3 (horizontally-striped bars). Significant p-value from chi-square test across CD4 categories.
Figure 2
Figure 2
Prevalence of specific activity limitations for participants with CD4 counts ≤ 200 cells/mm3 (speckled bars), 201 to 500 cells/mm3 (downward diagonally-striped bars) and > 500 cells/mm3 (horizontally-striped bars). Significant p-value from chi-square test across CD4 categories.
Figure 3
Figure 3
Prevalence of specific participation restrictions for participants with CD4 counts ≤ 200 cells/mm3 (speckled bars), 201 to 500 cells/mm3 (downward diagonally-striped bars) and > 500 cells/mm3 (horizontally-striped bars). Significant p-value from chi-square test across CD4 categories.

References

    1. Brashers DE, Neidig JL, Cardillo LW, Dobbs LK, Russell JA, Haas SM. "In an important way, I did die": Uncertainty and revival in persons living with HIV. AIDS Care. 1999;11:201–219. doi: 10.1080/09540129948090. - DOI - PubMed
    1. Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Sutten GA, Aschman PJ, Holmberg SD. Declining morbidity and mortality among patients with advanced HIV infection. N Engl J Med. 1998;338:853–860. doi: 10.1056/NEJM199803263381301. - DOI - PubMed
    1. Heath K, Hogg R, Singer J, Chan K, O'Shaughnessy M, Montaner J. Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based cohort. J Acquir Immune Defic Syndr. 2002;30:440–447. - PubMed
    1. Sowell RL, Phillips KD, Grier J. Restructuring life to face the future: The perspective of men after a positive response to protease inhibitor therapy. AIDS Patient Care STDS. 1998;12:33–42. - PubMed
    1. Nixon S, Renwick R. Experiences of Contemplating Returning to Work for People Living With HIV/AIDS. Qual Health Res. 2003;13:1272–1290. doi: 10.1177/1049732303257190. - DOI - PubMed

Publication types

MeSH terms